Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APTO | AZN | AMGN | GILD | BMY |
| Company | Aptose Bioscns | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.9900 | 190.33 | 368.27 | 143.50 | 59.92 |
| High | 1.9900 | 195.79 | 378.82 | 146.92 | 60.64 |
| Low | 1.3500 | 189.35 | 366.53 | 143.49 | 59.25 |
| Latest | 1.7100 | 194.95 | 376.97 | 146.63 | 60.63 |
| Change | -1.4400 | +0.73 | +7.44 | +2.70 | +0.34 |
| % Change | -45.71% | +0.38% | +2.01% | +1.88% | +0.56% |
| Volume | 670,300 | 1,875,000 | 2,720,100 | 5,210,500 | 10,964,601 |
| 20-Day Average Volume | 60,305 | 2,278,035 | 2,690,920 | 7,473,025 | 12,973,885 |
| Previous Close | 3.1500 | 194.22 | 369.53 | 143.93 | 60.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.4100 | 202.53 | 375.80 | 149.56 | 60.92 |
| 20-Day Raw Stochastic | 13.69% | 30.76% | 52.72% | 26.58% | 38.29% |
| 20-Day Relative Strength | 30.77 | 48.88 | 57.01 | 54.59 | 57.02 |
| Weighted Alpha | -90.45 | +31.12 | +28.96 | +38.44 | +15.60 |
| Today's Opinion | 100% Sell | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -50.86% since 03/25/25 | -4.31% since 03/02/26 | -2.26% since 03/02/26 | -2.27% since 03/02/26 | -2.74% since 03/02/26 |
| Low | 1.3500 on 04/01/25 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 3.7600 on 03/27/25 | 203.29 on 03/04/26 | 381.74 on 03/03/26 | 148.92 on 03/04/26 | 62.58 on 03/04/26 |
| 1-Month | |||||
| %Chg | -46.39% since 02/28/25 | +3.69% since 02/09/26 | +0.31% since 02/09/26 | -3.33% since 02/09/26 | -0.23% since 02/09/26 |
| Low | 1.3500 on 04/01/25 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 3.9799 on 03/18/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -74.70% since 12/31/24 | +8.52% since 12/09/25 | +20.11% since 12/09/25 | +22.85% since 12/09/25 | +19.70% since 12/09/25 |
| Low | 1.3500 on 04/01/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 7.7610 on 02/12/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -85.57% since 10/01/24 | +20.01% since 09/09/25 | +34.65% since 09/09/25 | +26.67% since 09/09/25 | +28.37% since 09/09/25 |
| Low | 1.3500 on 04/01/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 12.4860 on 11/11/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,661 | 302,349,504 | 203,212,464 | 182,029,584 | 123,471,424 |
| Shares Outstanding, K | 2,141 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -25,430,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -6,950,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.04 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -11.11 on 11/08/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/13/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.20 | 16.91 | 17.66 | 9.80 |